RTWG — RTW Biotech Opportunities Share News
0.000.00%
- £389.06m
- £395.25m
- $4.17m
Notice of AGM
Annual Financial Report
Brief: Rtw Venture Fund Ltd Announces A New Portfolio Company, Abdera Therapeutics
Director/PDMR Shareholding
Annual Financial Report
Director Declaration
Brief: RTW Venture Fund Says 4 Private Core Portfolio Cos, Totaling 1.68% Of NAV, Have Some Exposure To SVB
Brief: RTW Venture Fund Says NAV At Close Of Business On Jan 31 Was $346.7 Mln
Monthly Valuation Update
Portfolio Company Update
Brief: RTW Venture Fund Says 5.1% NAV Per Share Uplift For Quarter Ended Dec 31 2022
Quarterly Update
Update research from QuotedData
Net Asset Value(s)
Director/PDMR Shareholding
Result of General Meeting
Net Asset Value(s)
Edison issues flash on RTW Venture Fund (RTW)
Material Update from Portfolio Company